Stoke Therapeutics, Inc.STOKNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank88
Studio
Year-over-Year Change

Return on equity

Latest
-1.95%
↓ 109% vs avg
Percentile
P88
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
20.57%
Historical baseline
PeriodValueYoY Change
2025-1.95%+95.0%
2024-38.85%+40.8%
2023-65.62%-20.0%
2022-54.68%-38.8%
2021-39.40%-115.8%
2020-18.26%-26.8%
2019-14.40%-20.9%
2018-11.92%-102.8%
2017430.19%-